NishankJainMD

Physician

Dr. Jain is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
UAMS Medical Center
4301 W. Markham St.
Little Rock, AR 72205
Phone+1 501-686-8000

I am a board certified nephrologist and am very interested in kidney stones, glomerulonephritis and high blood pressure. My research focuses on cardiovascular complications of patients with kidney disease.

University of Texas Southwestern Medical CenterFellowship, Nephrology, 2010 - 2014
University of ConnecticutResidency, Internal Medicine, 2007 - 2010
Maulana Azad Medical CollegeClass of 2006

Chronic Kidney Disease (CKD) Platelet Study Start of enrollment: 2018 Nov 01
Completed
Phase 3

PubMed

1 citations
Platelets, inflammation, and purinergic receptors in chronic kidney disease.
Adam L Corken, Vincz Ong, Rajshekhar Kore, Sai N Ghanta, Oleg Karaduta
Kidney International. 2024-09-01
P2Y12 Inhibitors Refill Gap Predicts Death in Medicare Beneficiaries on Chronic Dialysis.
Rafia S Rasu, Milind A Phadnis, Christy Xavier, Junqiang Dai, Suzanne L Hunt
Kidney International Reports. 2024-07-01
Response to [Challenging the Restrictive Approach: Reconsidering SGLT-2 Inhibitor Use in CKD].
Tushar Tarun, Otis M Davis, Sai N Ghanta, Nishank Jain
Kidney International Reports. 2024-06-01

Journal Articles

Trends for and Clinical Factors Associated with Choice of Oral P2Y12 Inhibitors for Patients on Chronic Dialysis
2. Jain N, Hunt SL, Cui H, Phadnis MA, Mahnken JD, Shireman TI, Dai J, Mehta JL, Rasu RS, Cardiovasc Drugs Ther